{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:39:27Z","timestamp":1759588767482,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":1467,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.kint.2019.05.028","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T05:05:36Z","timestamp":1568869536000},"page":"815-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?"],"prefix":"10.1016","volume":"96","author":[{"given":"Alonso","family":"Marquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Batlle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.05.028_bib1","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.85.11.4095","article-title":"Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide","volume":"85","author":"Schiavone","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2019.05.028_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00109-017-1513-9","article-title":"Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II","volume":"95","author":"Maier","year":"2017","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.kint.2019.05.028_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","article-title":"Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme","volume":"31","author":"Chappell","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2019.05.028_bib4","doi-asserted-by":"crossref","first-page":"F1606","DOI":"10.1152\/ajprenal.00063.2012","article-title":"Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats","volume":"302","author":"Giani","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2019.05.028_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.kint.2019.04.024","article-title":"Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy","volume":"96","author":"Cassis","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.05.028_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/hy0302.104673","article-title":"Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles","volume":"39","author":"Ren","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2019.05.028_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2019.05.028_bib8","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2019.05.028_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2018.06.007","article-title":"Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor","volume":"50","author":"Gaidarov","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2019.05.028_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kint.2018.01.029","article-title":"Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation","volume":"94","author":"Liu","year":"2018","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381930612X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381930612X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:55:06Z","timestamp":1758761706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381930612X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S008525381930612X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.05.028","relation":{},"ISSN":["0085-2538"],"issn-type":[{"type":"print","value":"0085-2538"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.04.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}